Hans-Peter Rudolf

Hans-Peter Rudolf

Plus aucun poste en cours

58 ans
Commercial Services
Consumer Services
Health Technology

Profil

Hans-Peter Rudolf is currently a Director at Phosphate Therapeutics Ltd.
He previously worked as an Audit Partner at Ernst & Young LLP from 2003 to 2006, and as a Partner at Ernst & Young AG.
He was also the Head-Group Accounting at Bellefontaine Investments AG from 2011 to 2017, and an Audit Partner at Crowe LLP from 2006 to 2010.
From 2017 to 2020, he served as the Chief Financial Officer at Vicarius Pharma AG.
Rudolf holds an undergraduate degree from Cleveland State University and the University of Zurich.
He is currently the Chief Financial Officer at Shield Therapeutics Plc.

Postes actifs de Hans-Peter Rudolf

Anciens postes connus de Hans-Peter Rudolf

SociétésPosteFin
SHIELD THERAPEUTICS PLC Director of Finance/CFO 20/10/2023
Director of Finance/CFO 01/04/2020
Comptroller/Controller/Auditor 01/04/2017
Corporate Officer/Principal 01/12/2010
Corporate Officer/Principal 01/07/2006
Voir l'expérience en détail de Hans-Peter Rudolf

Formation de Hans-Peter Rudolf

Cleveland State University Undergraduate Degree
University of Zurich Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Hans-Peter Rudolf

Relations

100 +

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
SHIELD THERAPEUTICS PLC

Health Technology

Entreprise privées5

Commercial Services

Commercial Services

Commercial Services

Finance

Commercial Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Hans-Peter Rudolf